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A B S T R A C T
Organophosphates are applied for medicinal bath treatments of salmon lice (Lepeophtheirus salmonis) infested farmed salmonids. This chemical class remains im-
portant despite the development of resistant parasites, due to few available treatment options. The protective effect of the Phe362Tyr mutation in one of the
acetylcholinesterase (AChE) genes of L. salmonis has previously been studied in small-scale treatments with the organophosphate azamethiphos. The current study
was aimed at investigating the protective effect of this mutation in field treatments of commercial fish farms. In addition the effect of different methods of sampling
on the occurrence of salmon lice with zero, one or two copies of Phe362Tyr (homozygote sensitive (SS), heterozygote (RS) and homozygote resistance (RR) re-
spectively) were investigated.
Salmon lice were collected prior to and after azamethiphos treatments in four fish farms. The resistance genotypes were determined for each parasite. No SS lice
were found in any of the farms post-treatment. Both RR and RS genotypes protected the salmon lice from the effect of azamethiphos, but the protective effect of RR
genotype was greater than of RS. The study thereby emphasizes the strong selection pressure towards resistant parasites imposed by an azamethiphos treatment event
in farms where resistant parasites are present.
The distribution of SS, RS and RR genotypes were not found to differ between lice from different net pens, sampled at different dates or picked off fish of different
health statuses in a study with repeated sampling from a single farm.
1. Introduction
Salmon lice (Lepeophtheirus salmonis) are one of the biggest health
threats in the aquaculture of Atlantic salmon (Salmo salar) and rainbow
trout (Oncorhynchus mykiss) in the Northern Hemisphere (Torrissen
et al., 2013). The feeding behavior of these parasites poses a threat for
the fish. Aggregations of lice on fish can cause wounds, which may lead
to anemia, give rise to secondary infections and cause osmoregulatory
problems. A heavy lice load may even be fatal to the fish (Wagner et al.,
2008). The adult female parasites produce eggs that hatch into plank-
tonic larvae (Johnson and Albright, 1991). The larvae are spread by the
water current and parasites produced in one fish farm can thereby infest
both fish in nearby farms and wild salmonids (Kristoffersen et al., 2018;
Kristoffersen et al., 2014).
In most countries or regions farmers are subjected to regulations
giving maximum thresholds for salmon lice abundance (Fisheries and
Oceans Canada, 2016; Sernapesca, 2015; Ministry of Trade, Industry
and Fisheries, 2012). These regulations are in place to preserve farmed
fish health, control parasitic outbreaks and protect wild salmon stocks.
Norway is the world's largest producer of farmed Atlantic salmon and at
the same time the host of many wild salmonid populations (http://
www.fao.org/fishery/statistics/global-aquaculture-production/query/
en and https://lakseelver.no, accessed 08.08.18). In the case of
Norway, salmon lice thresholds are set to maximum 0.2 adult females
per fish during the wild smolt migration period and 0.5 adult females
per fish the rest of the year (Ministry of Trade, Industry and Fisheries,
2012).
Traditionally, salmon lice control has been accomplished using
medicinal treatments (Torrissen et al., 2013). The available medicines
belong to a few chemical classes and nearly all of the substances applied
have been on the market for several years. Reliance on a few chemical
classes and the frequent treatments over many years, have resulted in
resistant salmon lice. Many non-medicinal treatment options have been
developed to control salmon lice, but so far medicinal treatments are
still being use in salmonid production in all regions where salmon lice
or other sea lice must be controlled (Aaen et al., 2015).
One of the chemical classes applied against salmon lice are the or-
ganophosphates, which have been used for bath treatments of
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salmonids since the 1970s (Brandal and Egidius, 1979). The organo-
phosphate azamethiphos is applied in all salmonid producing countries
in the Atlantic Ocean and in Chile, for treatment against various sea lice
species (Aaen et al., 2015). Organophosphates inhibit the effect of
acetylcholine esterase (AChE), leading to a buildup of acetylcholine in
the synaptic cleft (Casida and Durkin, 2013). This hinders normal
neural impulses and the lice are paralyzed and fall off the fish.
Resistance in L. salmonis towards organophosphates has been known
since the 1990s in Europe (Jones et al., 1992). The resistance me-
chanism in L. salmonis towards organophosphates has been elucidated;
it is caused by a Phe362Tyr-mutation in one of the two L. salmonis genes
coding for AChE (Kaur et al., 2015a; Kaur et al., 2015b). A rapid mo-
lecular resistance test has been developed to detect this mutation. The
Phe362Tyr-mutation has since been detected along the Norwegian coast
and in all major salmonid producing areas in the Atlantic Ocean (Kaur
et al., 2017; Kaur et al., 2016). Organophosphate resistance is also
suspected in sea louse Caligus rogercresseyi, which is a common problem
in Chilean salmon farms (Agusti et al., 2016; Marín et al., 2015). A
mutation in one of the AChE genes of C. rogercresseyi is indicated to be
involved in organophosphate resistance (Agusti-Ridaura et al., 2018).
Resistance towards most of the other chemical classes available for
salmon lice treatments are also seen in all major salmonid producing
regions in the world, recently including British Columbia, Canada
(Messmer et al., 2018; Aaen et al., 2015). The use of azamethiphos has
therefore not terminated, despite of possible resistance. Knowing the
treatment effectiveness and thereby the effect on resistance selection
from treatments of lice with zero (SS), one (RS) or two (RR) copies of
the Phe362Tyr-mutation is important to avoid unsuccessful treatments,
and to understand variations in treatment effectiveness to prolong the
effectiveness of the chemical class for salmon lice treatments. Aza-
methiphos treatment efficacy, on SS, RS and RR lice, following la-
boratory treatments of salmonids infested with salmon lice has pre-
viously been studied (Jensen et al., 2017; Kaur et al., 2015b).
Treatment effectiveness has also been studied after field treatments in
commercial fish farms, but without knowledge of the drug resistance
status of sea lice on the farms (Jimenez et al., 2018; Gautam et al.,
2017).
The methods for sampling salmon lice for resistance testing have
previously not been investigated. The choice of method is not regulated.
Sampling could be performed relatively easily from available fish in the
water surface of a net pen using a dip net to catch fish. It could also be
performed in a more labor-intensive way, such as using a larger net to
first crowd the fish and thereafter using a dip net to select individual
fish, from different net pens ensuring a random selection of fish.
The aim of the current study was to examine the protective effect of
the Phe362Tyr-mutation in full-scale azamethiphos treatments against
salmon lice. An additional aim was to investigate if there were differ-
ences in the frequency of SS, RS and RR genotypes between lice sam-
pled from the same farm, but from different net pens, at different
sampling times or from fish of different health statuses.
2. Methods
2.1. Pre- and post-treatment sampling
Salmon lice were collected from four farms on the southwest coast
of Norway. The farms were selected because they had already decided
to treat their fish against salmon lice using azamethiphos. One net pen
was sampled in two farms and two net pens at the other two farms. The
same net pens were sampled pre- and post-treatment; March 2014 for
farm A, March and April 2014 for farm B, January and February 2015
for farm C and February 2015 for Farm D. The salmon lice were col-
lected from anesthetized fish, that were routinely selected for counting
lice on the farms according to Norwegian regulations acting for 2014
and 2015. These regulations implied that a minimum of 10 fish should
be randomly selected from the net pens (Ministry of Trade, Industry and
Fisheries, 2012). The exact number of fish the lice were collected from
is not known. The lice were fixed in 70% ethanol for later genotyping.
Sampled lice were of pre-adult and adult stages of both sexes and the
aim was to sample between 50 and 60 salmon lice at each net pen at
each sampling time, although this was not obtained post-treatment in
one of the net pens. Number of samples obtained, date of treatment and
the sampling times are presented in Table 1.
2.2. Treatments
Treatments were conducted with Salmosan® vet containing 500mg/
g of the active substance azamethiphos. Nominal Salmosan® con-
centrations in the treated net pens were 0.25 ppm (g/m3 water)
(0.125 ppm azamethiphos) in farms A, B and D and 0.3 ppm (0.15 ppm
azamethiphos) in farm C. Exposure time of fish to Salmosan® was re-
ported to be 60min for farms A, B and D and 47min for farm C. Water
temperatures varied from 6.5 to 7.4 °C between the treatments. The
number of fish in each treated net pen varied from approximately 42
000 to 174 000 (Table 2). All treatments were performed in non-
permeable tarpaulins set up around net pens where the water volume
had been reduced. Salmosan® was dissolved and distributed according
to the summary of product characteristics (SPC) (http://www.vmd.
defra.gov.uk/ProductInformationDatabase/, accessed 08.08.18). No
other treatments (medicinal or non-medicinal) were performed against
salmon lice from the date of the pre-treatment sampling till the date of
the post-treatment sampling.
Treatment effectiveness (TE (%)) was estimated by counting all











where X is the mean count of all mobile stages of lice of both sexes, i.e.
pre-adult and adult stages, and t0 and t1 are pre- and post-treatment
Table 1
Dates (dd.mm.yyyy) of treatment (tx), the number of genotyped salmon lice (N)
pre- and post-treatment and the sampling time as number of days pre- and post-
treatment, per farm and net pen. The farms are named by letters and the net
pens by numbers. Abundances of pre-adult and adult mobile lice (Lice ab.)
counted on a minimum of 10 fish, are given for the pre- and post-treatment days
















A1 25.03.2014 59 7 5.65 58 6 2.31
B1 31.03.2014 58 13 3.85 58 7 0.71
C1 26.01.2015 56 3 1.9 26 7 0.22
C2 24.01.2015 59 1 1.9 55 9 0.51
D1 18.02.2015 60 14 3.35 60 7 0.3
D2 18.02.2015 58 14 3.6 59 7 0.3
Table 2
Estimated treatment volume in m3, concentration of azamethiphos in g/m3
water, treatment time in minutes, treated number of fish, fish size in kg and
treatment density in kg fish per m3 water for the various net pens.
Farm and
net pen
Volume Cons. Treatm. time No. Fish Fish size Treatm.
Density
m3 g/m3 min kg kg fish/m3
A1 18,000 0.125 60 130,000 4.82 34.8
B1 17,000 0.125 60 160,700 4.38 45.6
C1 7000 0.15 47 68,686 1.9 18.6
C2 16,000 0.15 47 173,988 4.76 51.8
D1 4300 0.125 60 41,860 4.3 41.9
D2 6500 0.125 60 89,286 2.8 38.5
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respectively.
We also estimated the substance specific mortality of each genotype
of salmon lice, which was expressed as:


























where μ denotes mortality of the various genotypes, n is the total
number of lice in the sample, and t0 and t1 are pre- and post-treatment
respectively. Assuming 100% substance specific mortality of the SS
genotype and two scenarios (S1 and S2) for substance specific mortality
of the RR genotype, either 0% (Kaur et al., 2015b) or 19.1% (Jensen
et al., 2017), the substance specific mortality of the RS genotype could
be estimated by minimizing the difference between the expected and
observed proportions of the various genotypes post treatment:
− + − + −min SSobs SSexp RSobs RSexp RRobs RRexp(( ) ( ) ( ) )2 2 2
where obs denotes the observed proportion of the various genotypes
and exp. denotes expected proportions of the various genotypes for
given substance specific mortalities. The total substance specific effect
is then given by:
+ +μ SS μ RS μ RR
nt
( )1 2 3
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2.3. Study of sampling methods
A second study was also conducted to look at variation in the level
of salmon louse resistance to azamethiphos between net pens, over time
and between fish swimming in the water surface with non-normal
swimming behavior and the rest of the fish, within a farm. Salmon lice
were sampled from four net pens in a farm (farm E) located on the west
coast of Norway the 05.09.2016 (dd.mm.yyyy) and 12.09.2016, from
fish (unknown numbers) that were routinely subjected to lice counting
on the farm or removed from the net pen because they were regarded as
non-healthy, and fixed in 70% ethanol for later genotyping. No med-
icinal treatments against salmon lice were applied at the farm in the
period between the first and the last sampling. Both normal healthy
fish, and apparently non-healthy fish (fish swimming in the water
surface with non-normal swimming behavior), were sampled for lice.
Altogether 451 lice of pre-adult and adult stages of both sexes were
genotyped from this farm (Table 3).
2.4. Genotyping
Genotyping of the sampled salmon lice were performed by PatoGen
Analyse AS using a TaqMan assay specific for detecting the Phe362Tyr-
mutation. By combining TaqMan probes, each louse was classified as
homozygous sensitive (SS), heterozygous (RS) or homozygous resistant
(RR) according to Kaur et al. (2015b).
3. Results
3.1. Pre- and post-treatment sampling
A total of 350 and 316 salmon lice specimens were genotyped pre-
and post-treatment, respectively, from 4 farms and 6 net pens (Table 1).
The pre- and post-treatment proportions of the genotypes varied be-
tween the included net pens and farms, except for the proportion of SS
lice post-treatment (Fig. 1). The general trend seen in all net pens were
a complete extermination of SS lice post treatment and a that the
proportion of RR lice compared to RS lice increased post-treatment
compared to pre-treatment, indicating an increased treatment effec-
tiveness on RS lice compared to RR lice.
The estimated substance specific mortality of the RS genotype for
the six net pens, under the assumption of 100% mortality of the SS
genotype and either 0% (scenario 1) or 19.1% (scenario 2) mortality of
the RR genotype, are shown in Table 4.
Treatment effect varied from approximately 59% to 92% for the six
treatment units (Table 4). The estimated substance specific effects were
higher according to mortalities in scenario 2 compared to scenario 1,
but generally lower than the treatment effects (Table 4).
3.2. Study of sampling methods
Table 5 summarizes the proportions of the various genotypes of all
salmon lice sampled. The proportions are calculated for the categories;
net pens, sampling dates and fish health status. Similar proportions of
genotypes were found within each of these categories. There were no
significant differences in chi2 tests of the distribution of genotypes for
any of the compared categories of salmon lice specimens (net pens: d.f.
= 6, chi2=1.91, p=0.93; dates: d.f. = 2, chi2= 1.11, p=0.57; fish
health: d.f. = 2, chi2=1.67, p=0.43).
4. Discussion
The current study shows that the Phe362Tyr-mutation protects
salmon lice from dying during full-scale bath-treatments with the or-
ganophosphate azamethiphos. This is in accordance with previous re-
sults from small-scale laboratory treatments (Jensen et al., 2017; Kaur
et al., 2015b). The field treatment effectiveness on SS salmon lice was
estimated to be 100%. The effectiveness on RS lice was calculated to be
higher than on RR lice, under the assumption of either 0% or 19.1%
treatment effectiveness on RR lice. These two figures were found in
Kaur et al. (2015b) and Jensen et al. (2017) respectively. To calculate
the exact treatment effectiveness on RS and RR lice, all affected and
surviving lice from a group of fish should be sampled. However this is
difficult under field conditions.
Under the assumption of 0% and 100% treatment effectiveness on
RR and SS lice, respectively, mortality of the RS lice was calculated to
be between 43% and 88% for the treated net pens. When keeping the
assumption for SS lice while assuming a 19.1% treatment effectiveness
on RR lice, the mortality of the RS lice was calculated to be between
54% and 91% (Table 4). In the two laboratory studies the same figure
was 44% and 80%, Kaur et al. (2015b) and Jensen et al. (2017) re-
spectively.
The observed variability in RS mortality seen in the current study
could be explained by several different factors, such as exposure time,
treatment concentration and sampling error when sampling from a
heterogeneous population. The variability could also be caused by
practical treatment differences, such as difficulties in exposing all fish
to the same concentration throughout the entire treatment volume and
for the whole treatment period. Uneven distribution in time and space
(especially horizontally in the net pen) has been demonstrated using
fluorescein in addition to the treatment chemotherapeutant (Høy and
Oppedal, 2013). It is not possible to know the exact treatment con-
centration; the water volume in the flexible tarpaulin is affected by
Table 3
The number of genotyped salmon lice per net pen, sampled from apparently
non-healthy fish (fish swimming in the water surface with non-normal swim-
ming behavior) and healthy fish (all other fish). The number of salmon lice
samples on 05.09.2016 and 12.09.2016 respectively are provided in brackets.
Number of salmon lice at the two sampling dates (05.12.16, 12.09.16)
Net pen Healthy fish Apparently non-healthy fish
1 111 (54, 57) 3 (0, 3)
2 66 (36, 30) 35 (5, 30)
3 88 (55, 33) 29 (2, 27)
4 89 (59, 30) 30 (0, 30)
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water currents and analysis of azamethiphos concentration requires
laboratory facilities.
Another possible explanation to the observed variability could be
that salmon lice which survived the treatment as attached stages and
thereafter developed into pre-adults were sampled for the post-treat-
ment analysis. This is due to the fact that attached stages of salmon lice
are not affected by azamethiphos treatments (Roth et al., 1996). It is
however assumed to be a minor issue in the current study; no SS-lice
were detected post-treatment and these young pre-adults were to be
expected to have a genetic make-up more similar to the pre-treatment
status of the net pens, when SS-lice were found.
In studies of both L. salmonis and C. rogercresseyi increased
azamethiphos exposure time in farm treatments has shown to increase
field treatment effectiveness (Jimenez et al., 2018; Gautam et al.,
2017). In these studies resistance levels of the salmon lice were not
known and the effect of the potential interaction between resistance
genotype and exposure time on treatment effectiveness could therefore
not be elucidated. When comparing two laboratory treatment studies of
L. salmonis with azamethiphos applied at two different exposure times,
increased efficacy was seen after 60min compared to 30min exposure.
This was valid both for RS and RR lice (Jensen et al., 2017; Kaur et al.,
2015b). All SS parasites died in both these laboratory studies. In the
current study the RS mortality was closer to the level of mortality seen
in the laboratory study with 60min exposure and closest under an as-
sumption of 19.1% RR lice mortality compared to an assumption of 0%
mortality. This coincides with the field exposure times being closer to
60min (47 and 60min) as applied in the study by Jensen et al. (2017).
The field treatment effectiveness seen in the current study might also
have been influenced by the increase in treatment dose (0.125 and
0.15 ppm azamethiphos) compared to the concentration applied in
Jensen et al. (2017) and Kaur et al. (2015b) (0.1 ppm). The potential
effect of these two different exposure times could not be investigated in
the current study due to small sample size.
Uneven distribution of the chemotherapeutant throughout the water
volume, suggested to be a possible cause of variable RS mortality in the
present study, did not affect the SS mortality. This could be explained
by an extreme sensitivity of SS lice to azamethiphos exposure. In a
study by Roth et al. (1996), full treatment effectiveness was seen when
azamethiphos was applied at a dose of 0.05 ppm on known sensitive
populations of salmon lice (sensitivity was assessed in in-vitro bioassays
prior to treatment). The same study showed that applying
Fig. 1. Plot of salmon lice genotype proportions for azamethiphos resistance (homozygous sensitive (SS), heterozygous (RS) or homozygous resistant (RR)) in 6 net
pens from four salmon farms, pre and post azamethiphos treatment.
Table 4
The number of lice with given genotypes (homozygous sensitive (SS), heterozygous (RS) or homozygous resistant (RR) for the Phe362Tyr-mutation) pre- and post-
treatment (t0 and t1 respectively). μ2 expresses the proportional substance specific treatment mortality of the RS genotype, given proportional mortalities of the SS and
RR genotypes according to scenario 1 (S1) and scenario 2 (S2), respectively. The substance specific mortality of the SS genotype was set to 100% in both S1 and S2,
while it was set to 0% and 19.1% for the RR genotype in S1 and S2 respectively. Substance effect (%) is the estimated percentage reduction of the louse population in
the given net pen due to the substance specific effect of treatment for S1 and S2. Treatment effectiveness (%) is the percentage reduction in mean lice counts post-
treatment compared to pre-treatment.
Pre-treatment Post-treatment
Farm and net pen SSt0 RSt0 RRt0 SSt1 RSt1 RRt1 μ2S1 μ2S2 Substance effect S1 (%) Substance effect S2 (%) Treatment effectiveness (%)
A1 4 23 33 0 17 43 0.43 0.54 23.1 37.8 59.1
B1 7 29 22 0 15 44 0.74 0.79 49.1 58.8 81.6
C1 18 32 6 0 10 16 0.88 0.91 82.4 86.2 88.4
C2 23 28 8 0 24 27 0.75 0.79 74.6 79.1 73.1
D1 20 31 8 0 23 35 0.83 0.86 77.5 81.7 91.0
D2 18 31 8 0 26 29 0.77 0.81 73.5 78.3 91.7
Table 5
Proportion of salmon lice with different genotypes (homozygous sensitive (SS),
heterozygous (RS) or homozygous resistant (RR) for the Phe362Tyr-mutation)
in farm E presented according to the level of three different factors: net pen,
sampling date and fish health-status.
Unit SS RS RR
Net pen 1 0.11 0.55 0.34
Net pen 2 0.08 0.57 0.35
Net pen 3 0.10 0.55 0.35
Net pen 4 0.12 0.50 0.38
05.09.2016 0.10 0.56 0.33
12.09.2016 0.10 0.52 0.38
Healthy 0.11 0.53 0.36
Apparently non-healthy 0.07 0.59 0.34
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azamethiphos at a dose of 0.2 ppm increased the treatment effective-
ness in farms with resistant parasites compared to treatment using the
dose currently approved in the SPC of Salmosan® vet (0.1 ppm aza-
methiphos). This strategy was however not able to bring treatment ef-
fectiveness to the level seen at the farm with sensitive parasites (Roth
et al., 1996). If the azamethiphos resistance seen in the study by Roth
et al. (1996) was caused by the presences of the Phe362Tyr mutation in
the lice, the results indicate that treatment effectiveness of RR and/or
RS lice are concentration dependent. Kaur et al. (2017) showed the
presence of the Phe362Tyrmutation in salmon lice sampled in Scottland
in 2002, in Norway in 1998 and in Canada in 1999. It is therefore
possible that this mutation also was the cause of resistance in the early
1990s. In the current study the highest RS mortality was found in farm
C which used the highest treatment concentration (0.15 ppm aza-
methiphos), despite this farm using the shortest exposure time (47min).
Again the small sample size prevents firm conclusions.
Under the assumptions of 0% or 19.1% RR mortality and 100% SS
mortality, the overall anticipated substance specific treatment effec-
tiveness could be calculated. For all but one net pen (C2), this figure
was lower than the calculated treatment effectiveness based on pre- and
post-treatment lice counts. The observed additional effect of treatment
not explained by exposure to azamethiphos could be caused by non-
substance specific effects, such as the mechanical effects that might
cause salmon lice to be rubbed off the fish when the fish are crowded
during a treatment. This effect has previously been indicated for fresh
water well-boat treatments (Reynolds, 2015). The mechanical effects on
the lice during the course of a well-boat treatment are however most
likely greater than during a tarpaulin treatment, because of the
pumping of fish in and out of the well. Another possible explanation is
the sampling error that both estimation of genotype distribution and
treatment effectiveness is subjected to, especially due to small sample
sizes (Jimenez et al., 2012).
In the study by Roth et al. (1996) the farms with drug resistant
parasites showed inter-net pen variability in treatment effectiveness. No
significant inter-net pen difference in genotype frequency was found in
the current study. Variability was non-significant between different
sampling dates or between healthy and apparently non-healthy fish.
Sampling was however performed in one, single farm, possibly more
homogenous with regards to azamethiphos resistance than other farms,
and on two dates with just one week between. The strong genotype-
dependent mortality from azamethiphos treatments seen both in the
present and in previous studies (Jensen et al., 2017; Kaur et al., 2015b),
strongly indicate that if only single net pens on a farm have been
treated with azamethiphos, post-treatment inter-net pen heterogeneity
with regards to azamethiphos resistance is to be expected.
Knowing the protective effect of resistance genes in field treatments
is important in order to give good estimates of treatment effectiveness.
This knowledge can be further applied to optimize treatments and to
avoid unsuccessful treatments. The results also provide important
background information when trying to predict or hinder the devel-
opment of resistance at a farm or in a region, for example by providing
actual values for parameters of resistance in models by McEwan et al.
(2015, 2016).
The protective effect of the Phe362Tyr-mutation in the AChE of
salmon lice in laboratory treatments was also present in farm treat-
ments, as expected from the evolutionary success this mutation has
shown throughout the Atlantic Ocean (Kaur et al., 2017). This protec-
tive effect varied somewhat between treatment events. Since not all
factors affecting this variation are known, the exact treatment effec-
tiveness of a lice population containing RS and/or RR lice cannot be
calculated pre-treatment. The effect of a single azamethiphos treatment
on resistance selection can however be expected to be significant, since
all the SS and more than half of the RS lice of the affected life stages will
most likely will be killed by a treatment, thereby leaving few sensitive
alleles for the upcoming generations of lice.
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